Clinical trial
Erythropoietin Effects After Traumatic Brain Injury
NCT00260052 · Medical College of Wisconsin, Other · Withdrawn
Key facts
| NCT number | NCT00260052 |
|---|---|
| Title | Erythropoietin Effects After Traumatic Brain Injury |
| Official title | Phase II Study of the Effects of Erythropoietin on Neuronal Cell Death in Traumatic Brain Injury Patients |
| Lead sponsor | Medical College of Wisconsin, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | Erythropoietin administration |
| Enrollment | 0 |
| Start date | Jul 1, 2003 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Dec 1, 2005 |
| Last update posted | Aug 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: